Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment
ConditionKeloid Scars
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age10-50
SponsorNishtar Medical University
About this trial
This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.
Eligibility criteria
Qualifiers
size of keloid1-5 cm,
on any site of the body,
duration less then five years and
baseline Vancouver scar score of more the or equal to 5
Disqualifiers
Pregnant or lactating women,
family history of keloids,
acromegaly, and
congestive cardiac diseases
Trial design
Treatments tested in this trial
- Triamcinolone Acetonide 1 ml of 40 mg/mL suspension
- Verapamil Injection
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov